The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| JWEL | +19.21% | +16.64% | +3.13% | +153% |
| S&P | +14.43% | +77.25% | +12.13% | +186% |
Jamieson Wellness, Inc. engages in the manufacture and sale of sports nutrition products and specialty supplements. It operates through Jamieson Brands and Strategic Partners segments. The Jamieson Brands segment comprises manufacture, distribution, and marketing of branded natural health products including vitamins, minerals, and supplements. The Strategic Partners segment offers contract manufacturing services to consumer health companies and retailers worldwide. The company was founded in 1922 and is headquartered in Toronto, Canada.
No news articles found for Jamieson Wellness.
| Q3 2025 | YOY Change | |
|---|---|---|
| Revenue | $199.33M | 13.2% |
| Gross Profit | $83.62M | 23.7% |
| Gross Margin | 41.95% | 3.6% |
| Market Cap | $1.52B | 3.7% |
| Net Income | $15.51M | 48.9% |
| EBITDA | $34.03M | 19.4% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q3 2025 | YOY Change | |
|---|---|---|
| Net Cash | $48.82M | 15.7% |
| Accounts Receivable | $149.37M | 10.5% |
| Inventory | 236.6 | 22.3% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $444.08M | -1.2% |
| Short Term Debt | $17.69M | -30.9% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Return On Assets | 5.31% | 1.8% |
| Return On Invested Capital | 7.20% | -0.3% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | $4.41M | -80.1% |
| Operating Free Cash Flow | $7.67M | -68.3% |
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Earnings | 29.51 | 23.77 | 25.56 | 24.25 | -34.81% |
| Price to Book | 3.46 | 2.54 | 3.05 | 3.23 | -2.07% |
| Price to Sales | 2.16 | 1.71 | 2.00 | 1.98 | -6.98% |
| Price to Tangible Book Value | -7.63 | -8.03 | -8.33 | -8.60 | 22.85% |
| Price to Free Cash Flow TTM | 83.70 | 22.82 | 25.95 | 38.71 | -76.47% |
| Enterprise Value to EBITDA | 37.71 | 207.40 | 69.47 | 59.27 | -14.78% |
| Free Cash Flow Yield | 1.2% | 4.4% | 3.9% | 2.6% | 324.90% |
| Return on Equity | 11.0% | 11.6% | 12.7% | 13.4% | 52.53% |
| Total Debt | $426.90M | $437.48M | $448.85M | $461.77M | -2.80% |
No podcast episodes available.
No transcripts available.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
